skip-to-main

Spikevax bivalent Original / Omicron 0.1 mg/mL dispersion for injection

Spikevax bivalent Original / Omicron is indicated as a booster dose for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Spikevax (previously COVID‑19 Vaccine Moderna)

The Brunei Darussalam Medicines Control Authority (BDMCA) has granted Special approval for Spikevax during public health emergency or pandemic situation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Tools

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

    © 2023 Moderna, Inc.

    BN-COV-2100001 09/2022